Methylphendidate Treatment of Cocaine Dependent Patients With Attention Deficit Hyperactivity Disorder - 3
Status:
Completed
Trial end date:
1999-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate the feasibility of methylphenidate (MPD) as
effective and safe in the outpatient treatment of cocaine-dependent patients with a comorbid
DSM-IV diagnosis of Attention Deficit Hyperactivity Disorder (ADHD), to demonstrate the
ability of each site to participate in a subsequent anticipated controlled trial of MPD
(recruitment and execution), and to gather preliminary data on the ability of sweat patches
to detect episodes of cocaine use.